Page 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D.C. 20549 FORM 10 - Q ( Mark One ) □ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended : June 30 , 2021 □ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number : 001-37606 ANAVEX LIFE SCIENCES CORP . ( Exact name of registrant as specified in its charter ) Nevada ( State or other jurisdiction of incorporation or organization ) 98-0608404 ( IRS Employer Identification No. ) 51 West 52nd Street , 7th Floor , New York , NY USA 10019 ( Address of principal executive offices ) ( Zip Code ) 1-844-689-3939 ( Registrant's telephone number , including area code ) N / A ( Former name , former address and former fiscal year , if changed since last report ) Securities Registered Pursuant to Section 12 ( b ) of the Act : Title of Each Class Common Stock Par Value $ 0.001 Trading Symbol AVXL Name of Each Exchange on Which Registered NASDAQ Stock Market LLC